Safety and efficacy of TRIplet combination of nivolumab (N) with dabrafenib (D) and trametinib (T) [TRIDeNT] in patients (pts) with BRAF-mutated metastatic melanoma (MM): A single center phase II study
Year: 2019
Type: article
Study design: Clinical Trial
Source: Annals of Oncology
Authors: E.M. Burton, R.N. Amaria, I.C. Glitza, M. Shephard, A. Diab, D. Milton, S. Patel, J. Mcquade, M. Wong, P. Hwu, J. Wargo, M.A. Davies, H.A. Tawbi
Language: English
Topic: Melanoma and MAPK Pathways
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: bronze
OpenAlex ID: W2977494757